pubmed-article:3795083 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C0026649 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C0034493 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C0242692 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C1179435 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C0028066 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C0039629 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C1706211 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C1705248 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C0007961 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C1548799 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C1546426 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C1524073 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C1548280 | lld:lifeskim |
pubmed-article:3795083 | lifeskim:mentions | umls-concept:C0449432 | lld:lifeskim |
pubmed-article:3795083 | pubmed:dateCreated | 1987-2-19 | lld:pubmed |
pubmed-article:3795083 | pubmed:abstractText | The effects of tetracaine and nifedipine on asymmetric charge movement in rabbit muscle fibres were examined to investigate whether mammalian charge movement could be subdivided into several components. Tetracaine (0.05-0.2 mM) stopped contraction in every sternomastoid fibre examined (n = 9) and reduced the asymmetric charge (moved by depolarizing steps to 0 mV) by 15% (S.E. of mean 3%). Tetracaine had little effect on the charge moved at potentials more negative than the threshold potential (established in the absence of the drug). Application of the Ca2+ channel blocker nifedipine (2 or 10 microM), reduced the mean maximum asymmetric charge to 50% (+/- 4) of the control value in twenty-three sternomastoid fibres and to 32% (+/- 5) in four soleus fibres. Increasing the concentration of nifedipine to 120 microM had little further effect. The charge moved at potentials more negative than -60 mV was unaffected by nifedipine. A similar result was found with 30 microM-D600 (two fibres). 10 microM-nifedipine completely blocked Ca2+ currents (external [Ca2+] = 8 mM), but 0.15 microM-nifedipine only had a small effect on either the Ca2+ current or charge movement in the four fibres examined. Contractions could no longer be elicited in eleven of eighteen fibres within 6 min of the application of 2 or 10 microM-nifedipine. However, in the remaining seven fibres contractions could be elicited with unchanged thresholds over 30 min, even in the presence of 50 microM-nifedipine. Nifedipine did not noticeably effect q gamma. It is suggested that nifedipine might prevent contraction only when, for other reasons, the normal release of Ca2+ from the sarcoplasmic reticulum has been disrupted and contraction is dependent on the inflow of external Ca2+. The amount of asymmetric charge moved by depolarizing steps was about 50% greater with a holding potential of -110 mV than with one of -90 mV. This 'extra' charge was not suppressed by nifedipine. | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:language | eng | lld:pubmed |
pubmed-article:3795083 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3795083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3795083 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3795083 | pubmed:month | Jul | lld:pubmed |
pubmed-article:3795083 | pubmed:issn | 0022-3751 | lld:pubmed |
pubmed-article:3795083 | pubmed:author | pubmed-author:LambG DGD | lld:pubmed |
pubmed-article:3795083 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3795083 | pubmed:volume | 376 | lld:pubmed |
pubmed-article:3795083 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3795083 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3795083 | pubmed:pagination | 85-100 | lld:pubmed |
pubmed-article:3795083 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
pubmed-article:3795083 | pubmed:meshHeading | pubmed-meshheading:3795083-... | lld:pubmed |
pubmed-article:3795083 | pubmed:meshHeading | pubmed-meshheading:3795083-... | lld:pubmed |
pubmed-article:3795083 | pubmed:meshHeading | pubmed-meshheading:3795083-... | lld:pubmed |
pubmed-article:3795083 | pubmed:meshHeading | pubmed-meshheading:3795083-... | lld:pubmed |
pubmed-article:3795083 | pubmed:meshHeading | pubmed-meshheading:3795083-... | lld:pubmed |
pubmed-article:3795083 | pubmed:meshHeading | pubmed-meshheading:3795083-... | lld:pubmed |
pubmed-article:3795083 | pubmed:meshHeading | pubmed-meshheading:3795083-... | lld:pubmed |
pubmed-article:3795083 | pubmed:meshHeading | pubmed-meshheading:3795083-... | lld:pubmed |
pubmed-article:3795083 | pubmed:meshHeading | pubmed-meshheading:3795083-... | lld:pubmed |
pubmed-article:3795083 | pubmed:meshHeading | pubmed-meshheading:3795083-... | lld:pubmed |
pubmed-article:3795083 | pubmed:meshHeading | pubmed-meshheading:3795083-... | lld:pubmed |
pubmed-article:3795083 | pubmed:year | 1986 | lld:pubmed |
pubmed-article:3795083 | pubmed:articleTitle | Components of charge movement in rabbit skeletal muscle: the effect of tetracaine and nifedipine. | lld:pubmed |
pubmed-article:3795083 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3795083 | pubmed:publicationType | In Vitro | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3795083 | lld:pubmed |